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Abstract 
 
Overexpression of HER2 in breast cancer cell is found on invasive breast cancer and 
correlated with worse prognosis. Caesalpinia sappan L shows cytotoxic activity on various cancer cells. 
The goal of this research is to determine the cytotoxic activity and inhibition of migration and invasion 
of ethyl acetate fraction of Caesalpinia sappan L. (FEA) on HER2 overexpression-breast cancer cells 
(MCF-7/HER2). The MTT and flow cytometry assay showed that FEA revealed cytotoxic effect in a 
dose-dependent manner (IC50= 34±3.1 µg/mL) and induced apoptosis, S and G2/M phase 
accumulation. Wound healing assay, gelatin zymography and immunoblotting assay showed that FEA 
inhibited migration and suppressed MMP2, MMP9, HER2 and Rac1 protein level. Thus, ethyl acetate 
fraction of Caesalpinia sappan L. is potential to be developed on future research especially to treat 
metastatic breast cancer with HER2 overexpression. 
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INTRODUCTIONS 
 
 Several studies reveal the potential effect of 
Caesalpinia sappan L. and its compounds for cancer 
treatment (Kim, et al., 2005; Laksmiani, et al., 2015; 
Nirmal, et al., 2015; Nurzijah, et al., 2012) due to its 
major compounds. Brazilin and brazilein isolated 
from Caesalpinia sappan L. inhibit cancer cell 
growth through inducing of cell cycle arrest and 
apoptosis on cancer cells (Kim, et al., 2012; Tao, et 
al., 2011, 2013). Moreover, brazilein also inhibit 
migration of cancer cells, MDAMB-231 (Hsieh, et 
al., 2013). Migration and invasion are the important 
processes in early step of metastasis event (Brooks, 
et al., 2010). Thus, Caesalpinia sappan L. shows a 
promising anticancer agent targeted on the inhibition 
of proliferation and metastasis.  
The ErbB2/HER2 (epidermal growth factor 
receptor 2) is a member of the epidermal growth 
factor receptor (EGFR) that is observed abundant in 
many human cancers especially breast cancer and 
related with invasive, drug resistance and poor 
prognosis.  ErbB2 is also believed as a biomarker for 
invasive breast cancer, hence a potential therapeutic 
target (Brix, et al., 2014). Once HER2 receptor 
activated, it transduces intraselluler signals through 
several signaling cascades, including MAPK and 
NF-κB activation to induce cells proliferation and 
migration (Knuefermann, et al., 2003; Merkhofer, et 
al., 2010). Overexpression HER2 increases 
maintaining of Src activation resulting in MAPK 
activation through Raf Kinase to activate cells 
proliferation. In other event, activation of Src 
together with p120 catenin
 
(p120) and Vav2 
activates small Rho-GTPase protein (Rac1,cdc42 
and RhoA) and modulate cell migration (Johnson, et 
al., 2010). However, down regulation of Rac1 
protein expression reduces the migration and 
invasion potential of cancer cells (Chen, et al., 
2011). Hence, inhibition of HER2 mediated-
signaling pathways is essential to abrogate the 
proliferation and metastasis of HER2 over-
expressing cancer cells. 
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In our previous result showed that ethanolic 
extract of C. sappan performed inhibitory effect on 
MCF7 and 4T1 breast cancer cells (Handayani, et 
al., 2016). Ethanolic extract suggest to contain too 
many compounds, whereas, brazilin and brazilein as 
well as other major phenolic compounds thought to 
contribute significantly in the cytotoxic effect 
against cancer cells (Kim, et al., 2012, 2005; 
Laksmiani, et al., 2015; Nurzijah, et al., 2012).  
 It is well known that some phenolic 
compounds, including brazilein and brazilin, in 
ethanolic extract can be fractionated by ethyl acetate 
solvent to obtain a purified extract (Nirmal, et al., 
2015). The purified extract is valuable to be used in 
phytomedical practices due to the more concentrated 
active compounds with less abundant material and 
easier to achieve chemically standard reliability. 
Therefore, the purpose of this research is to explore 
the effect of ethylacetate fraction of C. sappan on 
metastatic human breast cancer cells especially in 
HER2 overexpressed breast cancer cells focusing on 
its proliferation and migration. 
 
MATERIALS AND METHODS 
 
Preparation of samples  
Dried heartwoods powder of Caesalpinia 
sappan L. was obtained from B2P2TOOT 
Tawangmangu, Indonesia. Dried powder was 
extracted in methanol to get methanol extract. The 
methanol extract was diluted by methanol: water 
(4:1) and then partitioned with hexane. The aqueous 
layer was fractioned with ethyl acetate and 
concentrated with vacuum rotary evaporator to get 
fraction of ethyl acetate (FEA).  
 
Cell culture 
MCF-7/HER2 and MCF-7/empty factor 
(MCF-7/Mock) cell line were kindly given from 
Prof.Dr. Yoshio Inouye through Prof. Dr. Mashashi 
Kawaichi (NAIST, Japan) and were cultured in 
CO2 incubator (37ᵒC) with Dulbecco's Modified 
Eagle Medium (DMEM) medium (Gibco) contained 
10% Fetal Bovine Serum (Gibco), 1.5% Penicillin-
Streptomycin (Gibco) and 0.5% fungizone (Gibco). 
MDAMD-231 cell line was kindly given from Prof. 
Dr. Mashashi Kawaichi (NAIST, Japan) and was 
cultured in non-CO2 incubator (37ᵒC) with L-15 
medium (Sigma) contained 15% Fetal Bovine Serum 
(Gibco), 1.5% Penicillin-Streptomycin (Gibco) and 
0.5% fungizone (Gibco). 
 
Cytotoxic assay in single and combination of 
samples 
MCF-7/HER2 cells were seeded in 96-well 
plates with 10
4 cells/well. After confluent, cells were 
treated with various concentration of treatment 
groups. After 24 h incubation, culture medium was 
removed and cells were washed in PBS (Sigma). 
Then, cells were incubated with 100 µL culture 
medium and 10 µL MTT (Sigma) 5 mg/mL in every 
well for 4 h.   MTT reaction was stopped by SDS 
reagent (10% sodium dodecyl sulphate (Merck) in 
0.01M HCl (Merck)) and was incubated overnight. 
The absorbance was measured by microplate reader 
(Bio-Rad) at wave length of 595 nm.  
 
Cell cycle distribution 
Propidium iodide (PI) staining kit (Becton 
Dickinson) was used to analyze DNA content. 
Cells were seeded in 24-well plates with 5x10
4 
within 24-48 h (to yield 60–70% confluence). Cells 
were treated with ½ IC50 of sample. After a 24-h 
treatment,  cells were harvested, and  the  cells were 
resuspended in PBS, fixed with 70% ethanol, 
labeled with PI (2 µg/mL), and incubated at room  
temperature  in the dark for 10 min. DNA  content  
was analyzed using a Flow cytometry (Becton 
Dickinson) and followed by flowing software 
(version 2.5.1).  
 
Apoptosis detection 
Apoptotic population was determined by PI-
Annexin V assay (Annexin V-FITC Apoptosis 
Detection Kit Roche). Cells were seeded in 24-well 
plates with 5x10
4 within 24-48 h (to yield 60–70% 
confluence). Cells were treated with ½ IC50 of 
sample. After a 24-h treatment, cells were 
harvested, added with 1x binding buffer, labeled 
with PI-Annexin V, and incubated at room 
temperature in the dark for 5 min. Then the cells 
suspension was  analyzed using a Flow cytometry 
(Becton Dickinson). 
 
Wound healing assay 
Cells were seeded in each well of 24-well 
plate with 1×10
5
 cells and incubated at 37ᵒC in CO2 
incubator for 24h. Thereafter cell were starved by 
using serum free-medium (containing 0.5% fetal 
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bovine serum) for 24 h. The confluent cell 
monolayers were wounded by a yellow-tip. After 
washing once with PBS, the cells were added with 
DMEM culture medium which contained of 1/4 IC50 
of sample. Time-lapse images were acquired at 0, 
18, and 24 h. Percent of closured were analyzed by 
using Image-J software. 
 
Gelatin zymography 
MMP-9 and MMP2 activity was assayed by 
gelatin zymography. Cells were seeded in each well 
of 6-well plate with 1×10
6
 cells and incubate at 37ᵒC 
in CO2 incubator for 24 h. Cells were incubated with 
1/4 IC50 of sample in serum free-medium for 24 h. 
The supernatants were collected and subjected to gel 
electrophoresis on 10% running gel containing 0.1% 
gelatin. The gel were washed in renaturing solution 
containing 2.5% Triton x-100 for 30 min, and 
followed by incubation for 20 h at 37ᵒC with 
incubation buffer. The gels were stained for 30 min 
in 0.5% commassie brilliant blue and destained with 
destaining solution (10% v/v methanol and 5% v/v 
acetic acid). After that, gel were scanned and 
documented. 
 
Immunoblotting 
Cells were seeded in 10 cm cultured dish with 
1×10
6
 cells and incubate at 37ᵒC in CO2 incubator 
for 24h. Cells were incubated with ¼ IC50 of sample 
for 24 h. Cell were collected with RIPA buffer (25 
mM Tris-HCl at pH 7.6, 150 mM NaCl, 1% NP-40, 
1% deoxycholic acid-Na, 0.1% SDS, proteases and 
phosphatase inhibitor cocktail). Protein samples 
were obtained using Bradford method and were 
measured by microplate reader (SH-1000, Corona 
electric), separated by electrophoresis on 7-15% 
SDS polyacrylamide gel electrophoresis (PAGE) 
gels, and electro-transferred onto PVDF transfer 
membranes (Immobilon, millipore). After blocking 
with 1x NET gelatin, the membranes were probed 
with antibodies for HER2 (sc-52349), p120 (sc-
13957) and ß-actin (sc-47778, Santa Cruz 
Biotechnologies, Santa Cruz, CA), and Rac-1 (ab 
33186, Abcam), then exposed to horseradish 
peroxidase (HRP)-conjugated secondary anti-mouse 
(sc-2031, Santa Cruz Biotechnologies, Santa Cruz, 
CA) or anti-rabbit antibodies (cs-7074P2, Cell 
signaling). Protein expression was examined using 
the enhanced chemiluminescence (ECL) system 
(Amersham).  
 
Statistical analysis 
Data were presented as the mean ± standard 
deviation (SD). The statistically signiﬁcant 
diﬀerences  between  the  control/untreated  group 
and  treated  groups  were  analyzed  by  Student t-
test. Mean differences was significant at the 
p<0.05. 
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RESULTS 
 
Cytotoxic assay of FEA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Cytotoxic activity of FEA on MCF-7/Mock and MCF-7/HER2. A. Morphology of MCF-7/HER2 cells after FEA 
(0-40 µg/mL) treatment, B. Cytotoxic activity of FEA on MCF-7/Mock, C. Cytotoxic activity of FEA on MCF-
7/HER2. Cells were treated with various concentration of samples for 24 h before assessed by MTT assay. Data was 
collected from three replications (*p<0.05).  
 
Firstly, it is important to confirm the cytotoxic 
activities of FEA on both MCF-7/Mock and MCF-
7/HER2 cells. Treatment of FEA induced the 
morphologycal alteration of MCF-7/HER2 cells 
(Fig. 1A) as well as MCF-7/Mock (data not shown). 
The FEA inhibited MCF-7/Mock and MCF-7/HER2 
cells growth with IC50 value 28±1.3 µg/mL and 
33.5±3.1 µg/mL (Fig. 1B-C) respectively. In order to 
investigate the mechanism of the cytotoxic effect of 
FEA, we observed the effect of FEA on cell cycle 
modulation and induction of apoptosis in the further 
study. 
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Cell cycle and apoptosis modulation of FEA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Cell cycle modulation and apoptosis induction of FEA on MCF-7/HER2 cells. Cells were treated with FEA 
(17.5 µM) for 24 h, incubated with PI or PI-Annexin V, measured by using flow cytometry and analyzed by using 
flowing software according to the method. A. Cell cycle distribution of FEA, B. Graphic of cell cycle distribution of 
FEA, C. Apoptotic cells distribution of FEA, D. Graphic of apoptotic cells distribution of FEA.  
 
 
Cell cycle analysis by using flow cytometry 
showed that treatment of 17.5 µg/mL FEA for 24 h 
caused increasing of sub-G1, S-phase and G2/M-
phase accumulation until 20.2%, 4.5%, and 2.7% 
respectively compared to untreated cells (Fig. 2A-B). 
The high cells accumulation on sub-G1 phase 
represents  the death cells. Nevertheless, to 
investigate that the death cells were due to apoptosis 
induction, it should be confirmed with PI-Annexin V 
flowcytometry analysis. We proved that FEA 
treatment induced total apoptosis up to 18.4% 
compared to untreated cells (Fig. 2C-D). Cytotoxic 
activity of FEA possibly through inducing of 
apoptosis and cells cycle accumulation in S-phase 
and G2/M-phase. 
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Inhibition of migration  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Effect of FEA on migration and invasion on cancer cells. A. wound closured on MDAMB 231 cells. Cells 
were scratched according to wound healing assay, were treated with 28.75 µg/mL FEA and were photographed at 0, 
18, 24, and 42 h. B. MMP9 and MMP2 activity on MCF-7/HER2. Cells were treated with 8.75 µg/mL FEA for 24 h and 
were observed by gelatin zymography. C. Graphic of MMP9 and MMP2 activity. Analysis of activity level of MMP9 and 
MMP2 was calculated by using image J software, Data was collected from three replications (*p<0.05). 
 
 
To study whether FEA inhibit migration and 
invasion, we tested the effect of FEA by wound 
healing assay and gelatin zymography. We used 
MDAMB 231 cells as a model for wound healing 
assay. The result showed that FEA inhibited wound 
closured on MDAMB 231 cells after 18 and 24 h 
incubation (Fig. 3A). MMP2 and MMP9 protein on 
microenvironment of cancer cells were important 
markers for migration and invasion cells. 
Furthermore, we tested the effect of FEA on MMP2 
and MMP9 protein expression of MCF-7/HER2 cells 
based on MMP2 and MMP9 activity by using gelatin 
zymography. Treatment of FEA decreased MMP2 
and MMP9 activity level on MCF-7/HER2 cells 
until 16% and 30% respectively (Fig. 3B-C). Based 
on the results, FEA inhibited migration and invasion 
on metastatic cancer cells.  
 
 
 
Inhibition of HER2 and Rac1 protein 
expression 
The HER2 pathway has an important role 
on migration and invasion of breast cancer cells. In 
this study, we observed the effect of FEA on 
modulation of HER2 protein expression on MCF-
7/HER2. The result showed that FEA decreased 
HER2 protein level (Fig. 4). The p120 is co-
regulator that has an important role on Rac1 
activation through HER2 signaling pathway 
(Johnson, et al., 2010). We also observed the effect 
of FEA on p120 and Rac1 protein expression that 
have a role on migration. The MCF-7/HER2 cells 
showed high level of p120 protein expression but 
had no effect after FEA treatment (Fig. 4). On the 
other hand, FEA decreased Rac1 protein level 
compared to untreated cells (Fig. 4). The FEA 
decreased HER2 and Rac1 protein level compared to 
untreated cells. 
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Figure 4. Effect of FEA in HER2, p120, and Rac1 protein expression in MCF-7/HER2 cells. Cells were treated with 
8.75 µg/ml FEA for 24 h and were observed by immunoblotting. 
 
DISCUSSIONS  
 
The development of antimetastatic agents 
from natural origin continuously is needed due to the 
complexity of metastatic feature of cancer cells. 
Here, we demonstrated C. sappan ethyl acetate 
fraction to inhibit metastatic breast cancer cells 
proliferation and migration. We found that FEA 
inhibit MCF7/HER2 cells as well as MCF7/Mock 
cells (Fig. 1). The differences of the IC50 values were 
not so wide, indicating that the two different cells 
character seemed to be responsive to FEA. This 
phenomenon indicates that FEA is possibly 
developed to treat breast cancer with high level of 
HER2. 
We also found that FEA performed strong 
inhibitory effect to the cells migration in 
MDAMB231 cells. This is an interesting finding 
since the mature cancer cells tend to be malignant 
phenotype with metastasis characteristic. MDAMB 
cells are human metastatic cancer cells through 
MAPK signaling and exhibit medium HER2 
expression (data not shown). However, whether FEA 
inhibits the cells migration through inhibition of 
MAPK has to be explored further, even in previous 
study suggest that brazilein inhibit NF-κB activation 
through inhibition of IKK (Hsieh, et al., 2013). 
Moreover, we found that FEA inhibited HER2 
expression indicating that there were possibly a 
correlation between the inhibitory effect on NF-κB 
activation and the lowering HER2 expression since 
NF-κB is known as transcriptional regulatory protein 
of HER2. 
Rac-1 and p120 are well known as the key 
regulators of HER2 overexpression-cells migration 
(Johnson, et al., 2010). Our findings suggest that 
FEA more affected to the Rac-1 expression rather 
than p120. These findings correlate to the inhibitory 
effect of cells migration indicating that the inhibitory 
effect of HER2 expression may correlate to the 
downregulation of Rac-1 expression but not p120 
and contribute to the inhibition of cells migration. 
This phenomenon is rather unique because it shows 
different evidence in which Rac-1 expression 
correlate with p120 level in HER2 expressing cells 
(Johnson, et al., 2010). Hsieh, et al. (2013) reported 
that brazilein inhibits migration through inhibition of 
PI3K and MAPK pathway leading to inhibition of 
NF-κB activation. Overexpression HER2 activates 
NF-κB (Merkhofer, et al., 2010). Rac-1 protein is 
also activated through PI3K pathway (Ridley, 2015). 
Further study focusing on Rac-1 activation and 
expression in correlation with NF-κB activation will 
elucidate more detail to these phenomena.  
Overall, our finding suggests that FEA is 
potential to be developed as antimetastatic cancer 
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with or without HER2 overexpression. This 
suggestion is also supported by the fact that FEA 
treatment decreased the expression of MMP9 and 
MMP2 significantly. MMP9 and MMP2 are 
extracellular enzymes secreted by the cells in which 
the expression levels were regulated by NF-κB 
activation (Hsieh, et al., 2013; Kim, 2010). Our 
findings provide information the possible inter-
correlation among HER-2 status, Rac1, MMP9, 
MMP2 and NF-κB activation. Further investigation 
to elucidate this phenomenon is interesting to gain 
the platform of this fraction to be used in 
phytomedical practices, especially to cure cancer 
metastasis in co-chemotherapeutics application. 
 
CONCLUSIONS 
 
This study confirms that FEA inhibits cell 
proliferation and migration on MCF-7/HER2 breast 
cancer cells possibly due to down regulation of 
MMP9, MMP2, HER2 and Rac1 protein expression. 
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